| Automatic cell counting with ImageJ IV Grishagin Analytical biochemistry 473, 63-65, 2015 | 229 | 2015 |
| The NCATS BioPlanet–an integrated platform for exploring the universe of cellular signaling pathways for toxicology, systems biology, and chemical genomics R Huang, I Grishagin, Y Wang, T Zhao, J Greene, JC Obenauer, D Ngan, ... Frontiers in pharmacology 10, 445, 2019 | 205 | 2019 |
| Lung fibrosis after COVID-19: treatment prospects E Bazdyrev, P Rusina, M Panova, F Novikov, I Grishagin, V Nebolsin Pharmaceuticals 14 (8), 807, 2021 | 154 | 2021 |
| In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics BB Lao, I Grishagin, H Mesallati, TF Brewer, BZ Olenyuk, PS Arora Proceedings of the National Academy of Sciences 111 (21), 7531-7536, 2014 | 119 | 2014 |
| In vivo anticancer activity of rhomboidal Pt (II) metallacycles IV Grishagin, JB Pollock, S Kushal, TR Cook, PJ Stang, BZ Olenyuk Proceedings of the National Academy of Sciences 111 (52), 18448-18453, 2014 | 101 | 2014 |
| Polyisobutylene-block-poly(methacrylic acid) Diblock Copolymers: Self-Assembly in Aqueous Media M Burkhardt, N Martinez-Castro, S Tea, M Drechsler, I Babin, I Grishagin, ... Langmuir 23 (26), 12864-12874, 2007 | 86 | 2007 |
| An integrative knowledge graph for rare diseases, derived from the Genetic and Rare Diseases Information Center (GARD) Q Zhu, DT Nguyen, I Grishagin, N Southall, E Sid, A Pariser Journal of biomedical semantics 11, 1-13, 2020 | 33 | 2020 |
| NCATS Inxight Drugs: a comprehensive and curated portal for translational research VB Siramshetty, I Grishagin, ÐT Nguyễn, T Peryea, Y Skovpen, ... Nucleic Acids Research 50 (D1), D1307-D1316, 2022 | 21 | 2022 |
| Low-dose salinomycin induces anti-leukemic responses in AML and MLL GDR Roulston, CL Burt, LMJ Kettyle, KB Matchett, HL Keenan, ... Oncotarget 7 (45), 73448, 2016 | 12 | 2016 |
| The hidden pandemic of COVID-19-induced organizing pneumonia E Bazdyrev, M Panova, V Zherebtsova, A Burdenkova, I Grishagin, ... Pharmaceuticals 15 (12), 1574, 2022 | 9 | 2022 |
| Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics PS Arora, B Olenyuk, BB Lau, I Grishagin US Patent 9,255,086, 2016 | 9 | 2016 |
| Mapping of UK Biobank clinical codes: Challenges and possible solutions O Stroganov, A Fedarovich, E Wong, Y Skovpen, E Pakhomova, ... Plos one 17 (12), e0275816, 2022 | 7 | 2022 |
| A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research G Zahoranszky-Kohalmi, VB Siramshetty, P Kumar, M Gurumurthy, ... Journal of chemical information and modeling 62 (3), 718-729, 2022 | 5 | 2022 |
| Pathways, Processes, and Candidate Drugs Associated with a Hoxa Cluster-Dependency Model of Leukemia LM Kettyle, CÉ Lebert-Ghali, IV Grishagin, GJ Dickson, PG O’Reilly, ... Cancers 11 (12), 2036, 2019 | 5 | 2019 |
| High-throughput screen identification of albendazole as a novel repurposed drug in acute myeloid leukaemia KB Matchett, IV Grishagin, L Kettyle, C Dowling, TN Chonghaile, KI Mills, ... Blood 130, 5062, 2017 | 3 | 2017 |
| Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics PS Arora, BB Lao US Patent 9,783,526, 2017 | 3 | 2017 |
| Mebendazole: A candidate FDA approved drug for repurposing in leukaemia KB Matchett, IV Grishagin, LM Kettyle, G Gavory, T Harrison, K Mills, ... XXXVI World Congress International Society of Haematology, 2016 | 3 | 2016 |
| Predicting patient treatment response and resistance via single-cell transcriptomics of their tumors S Sinha, R Vegesna, SR Dhruba, W Wu, DL Kerr, OV Stroganov, ... bioRxiv, 2022.01. 11.475728, 2022 | 1 | 2022 |
| PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors S Sinha, R Vegesna, S Mukherjee, AV Kammula, SR Dhruba, W Wu, ... Nature Cancer, 1-15, 2024 | | 2024 |
| Predicting patient treatment response and resistance via single-cell transcriptomics of their tumors E Ruppin, S Sinha, R Vegesna, A Kammula, SR Dhruba, W Wu, L Kerr, ... | | 2022 |
Bogdan OlenyukProteogenomics Research Institute for Systems MedicineVerified email at prism-sd.org
